These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8522488)

  • 1. Photopheresis for the treatment of cutaneous T-cell lymphoma.
    Lim HW; Edelson RL
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):1117-26. PubMed ID: 8522488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience.
    Heald PW; Perez MI; Christensen I; Dobbs N; McKiernan G; Edelson R
    Yale J Biol Med; 1989; 62(6):629-38. PubMed ID: 2534648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The application of photopheresis in the therapy of cancerous and autoimmune diseases].
    Dall'Amico R; Zacchello G; Heald P
    Recenti Prog Med; 1991 May; 82(5):294-9. PubMed ID: 1887157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cutaneous T-cell lymphoma.
    Zackheim HS
    Semin Dermatol; 1994 Sep; 13(3):207-15. PubMed ID: 7986690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
    McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
    Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
    Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
    Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.
    Bisaccia E; Gonzalez J; Palangio M; Schwartz J; Klainer AS
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
    Geskin L
    Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
    Ferenczi K; Yawalkar N; Jones D; Kupper TS
    Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis.
    Lee CH; Mamelak AJ; Vonderheid EC
    Int J Dermatol; 2007 Nov; 46(11):1198-204. PubMed ID: 17988344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasizing squamous cell carcinomas in a patient treated with extracorporeal photopheresis for cutaneous T-cell lymphoma.
    Hoetzenecker W; Benedix F; Woelbing F; Yazdi A; Breuninger H; Röcken M; Berneburg M
    Acta Derm Venereol; 2007; 87(5):445-6. PubMed ID: 17721661
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy.
    Heald P; Rook A; Perez M; Wintroub B; Knobler R; Jegasothy B; Gasparro F; Berger C; Edelson R
    J Am Acad Dermatol; 1992 Sep; 27(3):427-33. PubMed ID: 1401279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic applications of photopheresis.
    Rook AH; Cohen JH; Lessin SR; Vowels BR
    Dermatol Clin; 1993 Apr; 11(2):339-47. PubMed ID: 8477547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photopheresis: what is it and when should it be used?
    Scarisbrick J
    Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photopheresis in the treatment of cutaneous T-cell lymphoma: current status.
    Zic JA
    Curr Opin Oncol; 2012 Jan; 24 Suppl 1():S1-10. PubMed ID: 22157241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum soluble interleukin 2 receptor levels in erythrodermic cutaneous T-cell lymphoma correlate with response to photopheresis-based treatment.
    Goldman BD; Oh SK; Davis BE; Kadin ME; Poiesz BJ; Koh HK
    Arch Dermatol; 1993 Sep; 129(9):1166-70. PubMed ID: 8363402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: a report of 3 cases.
    Schreiner T; Gaczkowski A; Scharffetter-Kochanek K; Borberg H
    Transfus Apher Sci; 2005 Apr; 32(2):197-203. PubMed ID: 15784454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Documented effect of extra corporeal photopheresis on T-cell mediated diseases].
    Kofoed K; Schiødt I; Gniadecki R
    Ugeskr Laeger; 2011 Jun; 173(26):1869-74. PubMed ID: 21712008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience.
    Jiang SB; Dietz SB; Kim M; Lim HW
    Photodermatol Photoimmunol Photomed; 1999 Oct; 15(5):161-5. PubMed ID: 10540936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.